Mosby's Nursing Drug Reference
44
Quality Score
Emerging
✍️ GetAppValue analysis
“
Mosby's Nursing Drug Reference is an Android app from Skyscape Medpresso Inc in the Medical category, currently rated 3.4★ across 98 ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.
Quality Score is 44: Emerging (early traction worth watching). For a Medical app, that means early traction worth watching. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$5.0K
per month
→
12-mo forecast
$5.2K – $10.8K
per month
→
24-mo forecast
$6.4K – $19.2K
per month
MID tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
ONE-TIME · BUILD
💰 Estimated build cost
$145K
↳ What it cost to build · not monthly revenue
Likely range $110K – $195K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Slow ROI — current MRR is well below build cost
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 💎 In-app purchase plumbing | +$9K |
| ⚙ Medical complexity ×1.55 | +$32K |
| 🌐 Cross-platform reach (iOS + Android) | +$50K |
Total estimate
$145K
🔬
How we forecast this revenue
MEDIUM CONFIDENCEBaseline
$5.0K/mo · ML-estimated from 234 triggers
Growth rate
+4.0% MoM · MID tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition
6 months
$4.7K – $7.9K
12 months
$5.2K – $10.8K
24 months
$6.4K – $19.2K
Compound growth at +4.0% MoM (tier baseline for MID). Range widens with horizon — typical noise band ±25% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Below median · 50/100MID TIERunderperforming peersGrowth Velocity
5.0
Founder Strength
7.5
Product Quality
2.7
Revenue Strength
3.7
Monetization Maturity
4.0
Defensibility
9.8
Market Position
0.0
Operational Safety
7.0
- 💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 3.4★ across 98 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: last update 191d ago — slow cadence.
- ⚠️ Risk: Moderate — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $90K-$160K. Portfolio play ($90K/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 7 of 7 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| subscriptionREVIEW | +$2,500 | |
| excellent appREVIEW | +$1,500 | |
| Below-average rating (3.4★)METRIC | −$1,500 | |
| Mature app (9y old)METRIC | +$1,500 | |
| free trialREVIEW | +$1,200 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Pre-traction phase (98 ratings)METRIC | −$300 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Mosby's Nursing Drug Reference
- Developer
- Skyscape Medpresso Inc
- Bundle ID
- com.medpresso.Lonestar.rndrug
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.skyscape.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Reported revenue signal / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $327/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- $29.99 - $44.99 per item
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
“Try before you buy"-Download the FREE App,which includes sample content. In-App purchase required to unlock all content.
Based on 39th ed. Over 5,000 trade & generic name drugs-including 20-30 new entries for drugs recently approved by the FDA.Black Box Warnings. Coverage of IV drug administration. 26 built-in calculators.
Choose the drug handbook trusted by nurses for more than 35 years! Mosby's 2026 Nursing Drug Reference makes it easy to find the most vital information on the drugs you administer most frequently.… View full description on the official store →
Based on 39th ed. Over 5,000 trade & generic name drugs-including 20-30 new entries for drugs recently approved by the FDA.Black Box Warnings. Coverage of IV drug administration. 26 built-in calculators.
Choose the drug handbook trusted by nurses for more than 35 years! Mosby's 2026 Nursing Drug Reference makes it easy to find the most vital information on the drugs you administer most frequently.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →🔖 v3.13.1🔄 updated 0d ago📂 Medical💰 Free💎 IAP $29.99 - $44.99 per item
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
More by Skyscape Medpresso Inc
View all →📦 Portfolio summaryINDIE studio
175apps·$90K/mocombined
✓ Diversified — top app contributes 42%; risk spread across portfolio
About this analysis
Why low confidence: only 98 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does Mosby's Nursing Drug Reference make per month?▴
Based on our ML-calibrated revenue forecast, Mosby's Nursing Drug Reference earns approximately $194/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
What apps are like Mosby's Nursing Drug Reference?▴
Browse the full Medical category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes Mosby's Nursing Drug Reference?▴
Mosby's Nursing Drug Reference is published by Skyscape Medpresso Inc on the Google Play Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is Mosby's Nursing Drug Reference's BU Score?▴
Mosby's Nursing Drug Reference has a BU Score of 44/100 (Emerging). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.